Your browser doesn't support javascript.
Covid-19: All facts, no myth
Kathmandu University Medical Journal ; 18(2 COVID-19 Special Issue):80-89, 2020.
Article in English | EMBASE | ID: covidwho-2234127
ABSTRACT
On December 31, 2019, the China Health Authority alerted WHO about 27 cases of pneumonia of unknown etiology in Wuhan City. It was subsequently named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and the disease as Coronavirus Disease 2019 (COVID-19). The disease has now become pandemic. Current review was done to summarize information on COVID-19 published in various scientific works. Electronic databases containing medical articles viz., MEDLINE/PubMed, Google Scholar etc were searched using the Medical Subject Headings 'COVID-19', '2019-nCoV', 'coronavirus' and 'SARS-CoV-2' during antecedent one year. All study designs were incorporated to harvest clinical, laboratory, imaging, and hospital course data. The intermediate host of the virus is still unknown. Respiratory droplets produced by the patient is main source of transmission. SARS-CoV-2 invades the airway epithelium by binding to angiotensin-converting enzyme-2 (ACE2) receptor with Coronavirus spike (S) protein. Most common symptoms are fever (98%), dry cough (77%), and dyspnea (63.5%). Later, complications like acute respiratory distress syndrome, septic shock etc may occur. Advanced age and co-morbidities like Diabetes have higher mortality otherwise Case Fatality Rate is 2-3%. RT-PCR is the diagnosis of choice. Since no universally accepted registered drug or FDA approved vaccine has come by now, prevention is the key. Hands should be regularly cleaned with soap or alcohol based sanitizer and in public, Nose and Mouth should be covered with face-mask and social distance of one meter should be maintained. While Vaccines are expected by early 2021, we should not forget to take comprehensive measures to prevent future outbreaks of zoonotic origin. Copyright © 2020, Kathmandu University. All rights reserved.
Keywords
2019-nCoV; covid-19; Pandemic; SARS-CoV-2; adult respiratory distress syndrome; age; antiviral activity; antiviral therapy; article; avian influenza/dt [Drug Therapy]; case fatality rate; China; clinical feature; comorbidity; computer assisted tomography; convalescent plasma transfusion; coronavirus disease 2019/di [Diagnosis]; coronavirus disease 2019/dt [Drug Therapy]; coronavirus disease 2019/ep [Epidemiology]; coronavirus disease 2019/et [Etiology]; coronavirus disease 2019/pc [Prevention]; diabetes mellitus; drug efficacy; drug potency; dry cough; dyspnea; epidemic; fever; hand washing; health care personnel; human; immune response; immunomodulation; incidence; infection prevention; infection risk; isolation; laboratory test; Middle East respiratory syndrome/dt [Drug Therapy]; mortality; nonhuman; palliative therapy; passive immunotherapy; pneumonia; quarantine; real time polymerase chain reaction; respiratory epithelium; risk factor; septic shock; Severe acute respiratory syndrome coronavirus 2; social distancing; thorax radiography; virus cell interaction; virus culture; virus inhibition; virus pathogenesis; virus transmission; alcohol; angiotensin converting enzyme 2/ec [Endogenous Compound]; anti human immunodeficiency virus agent; azithromycin; canakinumab; Chinese medicinal formula; chloroquine/cm [Drug Comparison]; chloroquine/dt [Drug Therapy]; chloroquine/pd [Pharmacology]; coronavirus spike glycoprotein; hydroxychloroquine/cm [Drug Comparison]; hydroxychloroquine/pd [Pharmacology]; hydroxychloroquine sulfate; immunoglobulin; interferon; lopinavir plus ritonavir; macrolide; monoclonal antibody; peginterferon; remdesivir/dt [Drug Therapy]; remdesivir/pd [Pharmacology]; ribavirin; roflumilast; soap; umifenovir; unclassified drug; face mask; shufengjiedu

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Etiology study / Prognostic study / Reviews Topics: Vaccines Language: English Journal: Kathmandu University Medical Journal Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Etiology study / Prognostic study / Reviews Topics: Vaccines Language: English Journal: Kathmandu University Medical Journal Year: 2020 Document Type: Article